| Latest Vernalis Plc News Headlines |
| Date | Time | Source | |
| 11/19/2008 | 11:30AM | UKREG | Director Directorships Declaration
RNS Number : 5199I
Vernalis PLC
19 November 2008
19 November 2008
Vernalis plc (LSE: VER)
As required under Listing Rule 9.6.13, Vernalis plc announces that Ian Garland was previously a director of Acambis Plc. In addition,
as required under Listing Rule 9.6.13(3), David Mackney is a director... More...>> |
| 11/14/2008 | 12:06PM | TFNF | UPDATE 3-UK biotech firm Vernalis' new CEO pledges change
By Ben Deighton
LONDON, Nov 14 (Reuters) - Vernalis Plc on Friday appointed the former
management team from Acambis to head the British biotechnology company, and the
group's incoming Chief Executive promised significant changes.
Ian Garland -- who headed vaccine maker Acambis when it was sold to
Sanofi-Aventis... More...>> |
| 11/14/2008 | 7:22AM | TFNF | UPDATE 2-UK biotech firm Vernalis' new CEO pledges change
By Ben Deighton
LONDON, Nov 14 (Reuters) - Vernalis Plc appointed the former management team
from Acambis to head the British biotechnology company on Friday and the group's
incoming CEO promised significant changes.
Ian Garland -- who headed vaccine maker Acambis when it was sold to
Sanofi-Aventis... More...>> |
| 11/14/2008 | 4:36AM | TFNF | Glance-STOCKS NEWS EUROPE-Vernalis rises as Acambis team takes over
STOCKS NEWS Reuters Results diary
Europe Real-time Equity News
09:19GMT 14Nov2008-Vernalis rises as Acambis team takes over
----------------------------------------------------------------------------
Shares in UK biotech firm... More...>> |
| 11/14/2008 | 4:20AM | TFNF | STOCKS NEWS UK SMALL-Vernalis rises as Acambis team takes over
STOCKS NEWS Reuters Results diary
Europe Real-time Equity News
UK Stocks on the move
UK smallcaps
09:03GMT 14Nov2008-Vernalis rises as Acambis team takes over... More...>> |
| 11/14/2008 | 3:12AM | TFNF | UPDATE 1-Vernalis says ex-Acambis CEO and CFO to take over
LONDON, Nov 14 (Reuters) - British biotechnology company Vernalis Plc said
the former top two executives at UK vaccine specialist Acambis Plc are to take
over management of the company.
Ian Garland, former head of Acambis, to become its new chief executive,
while ex chief financial officer David Mackney... More...>> |
| 11/14/2008 | 2:01AM | UKREG | Appointment of new CEO and new CFO
RNS Number : 1507I
Vernalis PLC
14 November 2008
14 November 2008
Vernalis appoints new Chief Executive Officer
and Chief Financial Officer
Winnersh, UK, 14 November 2008, Vernalis plc (LSE: VER) today announces two key appointments. Firstly, Ian Garland (43) is named as
Chief Executive... More...>> |
| 11/14/2008 | 2:00AM | UKREG | Interim Management Statement
RNS Number : 1499I
Vernalis PLC
14 November 2008
14 November 2008
Vernalis plc: Interim Management Statement
for the period to 14 November 2008
Winnersh, UK, 14 November 2008, Vernalis plc (LSE: VER) today publishes its interim management statement for the period 1 July to 14
November... More...>> |
| 11/13/2008 | 11:43AM | UKREG | Second Price Monitoring Extn
RNS Number : 1434I
Vernalis PLC
13 November 2008
A Second Price Monitoring Extension has been activated in this security.
A Second Price Monitoring Extension is activated when the auction matching process would result in an auction price that is a
pre-determined percentage above or below the base... More...>> |
| 11/13/2008 | 11:37AM | UKREG | Price Monitoring Extension
RNS Number : 1422I
Vernalis PLC
13 November 2008
A Price Monitoring Extension has been activated in this security.
A Price Monitoring Extension is activated when the auction matching process would result in an auction price that is a pre-determined
percentage above or below the base price... More...>> |
| 11/06/2008 | 1:03PM | TFNF | BMS, Astra obesity drugs in doubt as rivals fail
By Ben Hirschler
LONDON, Nov 6 (Reuters) - The decision by Sanofi-Aventis and Pfizer to stop
development of a once-promising class of drugs for obesity casts a long shadow
over remaining experimental drugs of the same type.
The other most advanced so-called cannabinoid 1 (CB1) receptor
antagonists... More...>> |
| 10/31/2008 | 12:50PM | UKREG | Second Price Monitoring Extn
RNS Number : 2248H
Vernalis PLC
31 October 2008
A Second Price Monitoring Extension has been activated in this security.
A Second Price Monitoring Extension is activated when the auction matching process would result in an auction price that is a
pre-determined percentage above or below the base... More...>> |
| 10/31/2008 | 12:39PM | UKREG | Price Monitoring Extension
RNS Number : 2154H
Vernalis PLC
31 October 2008
A Price Monitoring Extension has been activated in this security.
A Price Monitoring Extension is activated when the auction matching process would result in an auction price that is a pre-determined
percentage above or below the base price.
The... More...>> |
| 10/28/2008 | 7:18AM | TFNF | BRIEF-Vernalis says CFO Tony Weir to leave company
LONDON, Oct 28 (Reuters) - Vernalis PLC:
* Announces today the forthcoming departure of Mr Tony Weir, chief financial
officer.
((London Equities Newsroom; +44 20 7542 7717))
tf.TFN-Europe_newsdesk@thomson.com
vs
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights... More...>> |
| 10/28/2008 | 7:00AM | UKREG | Directorate Change
RNS Number : 7975G
Vernalis PLC
28 October 2008
28th October 2008
Vernalis Announces Directorate Change
Vernalis plc (LSE: VER) announces today the forthcoming departure of Mr Tony Weir, Chief Financial Officer. He will be leaving on 14th
November 2008 to join another company in the life... More...>> |
| 10/22/2008 | 2:36AM | TFNF | BRIEF-Vernalis regains rights to inflammatory disease drugs
LONDON, Oct 22 (Reuters) - Vernalis PLC:
* Has regained all rights to a portfolio of compounds targeting the
treatment
of inflammatory disease
* Compounds were originally part of a licence, development and
commercialization agreement between Vernalis and Serono
((London Equities... More...>> |
| 10/22/2008 | 2:00AM | UKREG | Pipeline Update
RNS Number : 3838G
Vernalis PLC
22 October 2008
22 October 2008
Vernalis Bolsters Pipeline with Phase II -Ready Anti-Inflammatory Drug Candidate
Winnersh, UK, 22 October 2008, Vernalis plc (LSE: VER) today announces that, following the merger of Merck KGA and Serono, it has
regained... More...>> |
| 10/21/2008 | 7:14AM | UKREG | Holding(s) in Company
RNS Number : 3368G
Vernalis PLC
21 October 2008
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
Vernalis PLC
2. Reason for the notification (please place an X inside... More...>> |
| 10/20/2008 | 11:42AM | UKREG | Second Price Monitoring Extn
RNS Number : 2636G
Vernalis PLC
20 October 2008
A Second Price Monitoring Extension has been activated in this security.
A Second Price Monitoring Extension is activated when the auction matching process would result in an auction price that is a
pre-determined percentage above or below the... More...>> |
| 10/20/2008 | 11:38AM | UKREG | Price Monitoring Extension
RNS Number : 2610G
Vernalis PLC
20 October 2008
A Price Monitoring Extension has been activated in this security.
A Price Monitoring Extension is activated when the auction matching process would result in an auction price that is a pre-determined
percentage above or below the base price... More...>> |